PTX prescient therapeutics limited

Ann: December 2024 Quarterly Update and Appendix 4C, page-2

  1. 8,324 Posts.
    lightbulb Created with Sketch. 3661
    Interesting to see that the PTX-100 Phase 2 trial for CTCL has been clarified as an actual separate IND (ie not under the drug's original IND umbrella). All previous wording was somewhat vague. So, does this assign more value in terms of IP? Interested to get other views on this!

    Great to see the size of the R&D rebate and good to know we have 4 qtrs of funding.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
5.2¢
Change
-0.001(1.89%)
Mkt cap ! $41.87M
Open High Low Value Volume
5.3¢ 5.3¢ 4.9¢ $51.46K 1.024M

Buyers (Bids)

No. Vol. Price($)
1 18678 5.0¢
 

Sellers (Offers)

Price($) Vol. No.
5.2¢ 50000 1
View Market Depth
Last trade - 15.15pm 13/06/2025 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.